Patient Capital Management·CIK 1854794
40
Positions
$1.9B
Portfolio Value
17
Quarters tracked
Q4 2025
Latest filing
Portfolio Allocation — Q2 2024
Portfolio Value Over Time
| 3 | BIIB | 3.17% | $59,640,080 | ▲ +0.9% |
| 4 | EVRI | 0.65% | $12,291,321 | NEW |
| 5 | ILMN | 2.30% | $43,302,876 | ▲ +0.7% |
| 6 | C | 5.61% | $105,540,967 | ▲ +0.1% |
| 7 | BABA | 2.78% | $52,309,877 | ▲ +0.5% |
| 8 | AMZN | 6.48% | $122,075,429 | ▲ +0.8% |
| 9 | GM | 4.04% | $76,148,526 | ▲ +0.1% |
| 10 | PGEN | 1.53% | $28,715,960 | ▲ +0.3% |
| 11 | NCLH | 2.83% | $53,307,378 | ▲ +0.4% |
| 12 | KOS | 2.67% | $50,330,228 | ▲ +0.3% |
| 13 | ET | 4.62% | $86,949,854 | ▲ +0.3% |
| 14 | CVS | 2.32% | $43,687,207 | ▲ +0.1% |
| 15 | IAC | 3.97% | $74,841,411 | ▲ +0.2% |
| 16 | SDRL | 2.48% | $46,741,260 | ▲ +0.3% |
| 17 | META | 4.28% | $80,637,518 | ▲ +0.4% |
| 18 | SPY | 0.02% | $401,696 | NEW |
| 19 | GOOS | 2.67% | $50,224,446 | ▲ +0.2% |
| 20 | TEVA | 0.09% | $1,625,000 | ▲ +0% |